Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HILSNYSEARCA:KIENYSEAMERICAN:KLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHILSHillstream BioPharma$1.36-0.9%$1.35$0.19▼$2.65$23.90M3.081.39 million shs42,139 shsKIESPDR S&P Insurance ETF$57.72+0.1%$58.01$48.82▼$62.47$888.89M0.771.07 million shs1.30 million shsKLRKaleyra$7.24$7.24$1.57▼$7.25$96.51M1.75147,441 shsN/A7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHILSHillstream BioPharma+0.56%+2.08%+12.65%-28.55%+247.66%KIESPDR S&P Insurance ETF0.00%-3.35%+0.38%+1.26%+12.21%KLRKaleyra0.00%0.00%0.00%+84.69%+84.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHILSHillstream BioPharmaN/AN/AN/AN/AN/AN/AN/AN/AKIESPDR S&P Insurance ETFN/AN/AN/AN/AN/AN/AN/AN/AKLRKaleyraN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHILSHillstream BioPharma 0.00N/AN/AN/AKIESPDR S&P Insurance ETF 2.50Moderate Buy$57.72N/AKLRKaleyra 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHILSHillstream BioPharmaN/AN/AN/AN/A$0.48 per shareN/AKIESPDR S&P Insurance ETFN/AN/AN/AN/AN/AN/AKLRKaleyra$339.17M0.28$0.99 per share7.31$3.26 per share2.22Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHILSHillstream BioPharma-$8.47M-$0.72N/AN/AN/AN/A-188.44%-149.61%N/AKIESPDR S&P Insurance ETFN/AN/A12.16∞N/AN/AN/AN/AN/AKLRKaleyra-$98.53M-$6.84N/AN/AN/A-25.46%-57.22%-7.60%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHILSHillstream BioPharmaN/AN/AN/AN/AN/AKIESPDR S&P Insurance ETF$0.941.63%N/AN/AN/AKLRKaleyraN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHILSHillstream BioPharmaN/A3.013.01KIESPDR S&P Insurance ETFN/AN/AN/AKLRKaleyra7.671.391.39Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHILSHillstream BioPharma13.36%KIESPDR S&P Insurance ETFN/AKLRKaleyra43.00%Insider OwnershipCompanyInsider OwnershipHILSHillstream BioPharma30.24%KIESPDR S&P Insurance ETFN/AKLRKaleyra31.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHILSHillstream BioPharma117.60 million12.28 millionNot OptionableKIESPDR S&P Insurance ETFN/A15.40 millionN/ANot OptionableKLRKaleyra62013.33 million9.17 millionNot OptionableGFRD, HILS, KLR, and KIE HeadlinesRecent News About These CompaniesTata Communications Readies Kaleyra AI: The Game Changing, AI-Powered Future of Customer InteractionsDecember 13, 2024 | prnewswire.comAdventure MotorcyclesApril 27, 2024 | motorcyclistonline.comWeb Real Time Communication Solution Market to Soar: $9.3 Billion Projected in 2023, 44.2% CAGR Expected Through 2033February 27, 2024 | fmiblog.comTata Communications completes acquisition of Kaleyra, a leading global CPaaS platform playerOctober 5, 2023 | finance.yahoo.comKaleyra Appointed by stc Bahrain As Exclusive Omnichannel PartnerSeptember 21, 2023 | finance.yahoo.comKaleyra (KLR) Surges 6.2%: Is This an Indication of Further Gains?September 20, 2023 | finance.yahoo.comKaleyra, Inc. Special Meeting Reminder and Announcement of Recommendations by ISS and Glass Lewis that Stockholders Vote FOR the Proposed MergerSeptember 20, 2023 | finance.yahoo.comMoore Kuehn Encourages CELL, CCF, IMNM, and KLR Investors to Contact Law FirmSeptember 11, 2023 | benzinga.comKALEYRA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kaleyra, Inc. - KLRAugust 28, 2023 | businesswire.comKaleyra and Talisma Partner in India to Enhance Customer Experience with Real-Time Video and Co-BrowsingAugust 22, 2023 | finance.yahoo.comKaleyra Announces Changes in Management TeamAugust 11, 2023 | finance.yahoo.comKaleyra US: Kaleyra Announces Second Quarter 2023 ResultsAugust 8, 2023 | finanznachrichten.deKaleyra Announces Second Quarter 2023 ResultsAugust 8, 2023 | finance.yahoo.comKaleyra Brings WhatsApp Business Platform To US Solution Portfolio To Enhance Customer EngagementJuly 26, 2023 | finance.yahoo.comNorthland Capital Markets Downgrades Kaleyra (KLR)July 7, 2023 | msn.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Kaleyra, Inc. (NYSE – KLR)July 6, 2023 | benzinga.comKaleyra (KLR) Price Target Increased by 19.81% to 10.79July 6, 2023 | msn.comMoore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law FirmJuly 5, 2023 | benzinga.comIMPORTANT ALERT: Halper Sadeh LLC Investigates KLR, WMC, SGTXJuly 3, 2023 | bakersfield.comKLR stock rated a Hold by Craig HallumJuly 3, 2023 | knoxdaily.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGFRD, HILS, KLR, and KIE Company DescriptionsHillstream BioPharma NASDAQ:HILS$1.36 -0.01 (-0.91%) As of 05/23/2025Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.SPDR S&P Insurance ETF NYSEARCA:KIE$57.72 +0.03 (+0.05%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$57.54 -0.17 (-0.30%) As of 05/23/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The SPDR S&P Insurance ETF (the Fund), formerly SPDR KBW Insurance ETF, seeks to closely match the returns and characteristics of the S&P Banks Select Industry Index. The Fund invests all, but at least 80%, of its total assets in the securities comprising the Index. The Fund invests in all of the securities represented in the Index in approximately the same proportions as the Index. The S&P Banks Select Industry Index is a float adjusted modified-market, capitalization-weighted index that seeks to reflect the performance of publicly traded companies that do business as banks or thrifts. The S&P Banks Select Industry Index consists of common stocks of national money centers and regional banks or thrifts listed on the New York Stock Exchange (NYSE) or another United States national securities exchange (NASDAQ)/National Market System (NMS). SSgA Funds Management, Inc. (SSgA FM) serves as the investment adviser to the Fund.Kaleyra NYSEAMERICAN:KLR$7.24 0.00 (0.00%) As of 10/5/2023Kaleyra Inc., through its subsidiaries, provides mobile communication services to financial institutions, e-commerce players, OTTs, software companies, logistic enablers, healthcare providers and retailers, and other organization worldwide. The company provides cloud communications platforms, which manages multi-channel integrated communications services including inbound/outbound messaging solutions, programmable voice and interactive voice response configurations, hosted telephone numbers, conversational marketing solutions, rich communication services, and other IP communications, such as e-mail, push notifications, video/audio/chat, and WhatsApp services. It also enables its customers and business partners to connect enterprise software and applications to mobile network operators through application programming interfaces, which allows to build omnichannel. In addition, the company provides set of no-coding cloud-based visual interfaces to program communications to customers across multiple channels. Kaleyra, Inc. was founded in 1999 and is headquartered in Milan, Italy. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
